BIOCEV: Czech leukaemia treatment wants testing in Europe

Published: 26.08.2022 Related countries:  Korea (south) Korea (south)

in Europe, around 7,500 people are diagnosed every year

Based on a five-year-long clinical trial, a team of scientists and physicians from the BIOCEV Centre, Charles University’s First Faculty of Medicine, and General University Hospital in Prague has published a new approach to treating acute leukaemia. Their innovative method combines two drugs that have significantly prolonged patient survival when administered simultaneously. Because of anaemia, these patients are less resilient to bacterial and viral infections, for instance, pneumonia. The treatment can be immediately applied in practice. The team is now discussing expanding the trial to the European level.

Source: CIA News
Prepared by the team of foreign office CzechTrade and CzechInvest Seou